InsidersTradesSigma
신라젠: directors' dealings · South Korea · DART (FSS)
DART:company-3f9880KR·DART (FSS)Mcap 415.8Bn€Healthcare
Explore the full directors' dealings record of 신라젠, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 신라젠 has logged 1 insider filings. Market capitalisation: €415.8bn. The latest transaction was disclosed on 5 March 2026 (Other). Among the most active insiders: 신라젠. Every trade is openly available.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3010.00 €
Analyst consensus
Income statement
Revenue9.23 Bn€
Gross profit5.29 Bn€57% margin
Net income−24.19 Bn€-262.2% margin
Valuation
Beta0.04
Balance sheet & cash
Market cap415.77 Bn€
Total debt2.27 Bn€
Free Cash Flow−26.22 Bn€
Debt / Equity2%
Profitability & ownership
ROE-20.0%
ROA-12.0%
% insiders15.8%
% institutions0.3%
Last declaration on 5 March 2026
Declarations1 total
Executives●Other0DART
DART:20260305000144·details not loaded
1 of 1 declaration